Serenza Therapeutics

Private

LondonHealthcare & Life Scienceshttps://businessweekly.co.uk

Last Round

Series A

May 10, 2026

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Serenza Therapeutics is a biopharmaceutical company spun-out from Nxera Pharma to advance a preclinical GPCR-targeted program.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biopharmaceuticalGPCRG protein-coupled receptorpreclinical drug developmentbiotech spin-outdrug discoverybiotechdrug licensingpreclinical researchtherapeutic developmentbiotech startupdrug pipeline

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Serenza Therapeutics Comps

Public and private peers based on sector, stage, and business model.

Serenza Therapeutics comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Serenza Therapeutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series A	May 10, 2026

View all Funding Rounds

Serenza Therapeutics Investors

Notable investors and investment history

Serenza Therapeutics investors
Investor	Rounds
SV Health Investors	Series A

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

May 10, 2026
Nxera Pharma Co., Ltd. led the round.
Jan 19, 2025
Grew 19% QoQ, from 27 to 32 employees.

View all signals

Serenza Therapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Serenza Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Serenza Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersLondon

Employee Range30

Year Founded2026

Last FundingMay 10, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.